Silvano Cominelli

Chief Executive Officer at

GianCom AG

59 year

19 connections

Health Technology

Finance

Consumer Services

Profile

Silvano Cominelli is currently Chief Executive Officer & Chief Investment Officer at GianCom AG since 2017.
Formerly, Dr. Cominelli was Director at Broncus Technologies, Inc. from 2007 to 2013, Director at Pelikan Technologies, Inc., Director-Neurology Business Unit at Serono SA from 1998 to 2000, and Investment Advisor at HBM Partners AG (Investment Management).
Dr. Cominelli earned a doctorate from the University of Zurich in 1999.

Silvano Cominelli active positions

Companies	Position	Start
GianCom AG GianCom AG Investment ManagersFinance GianCom specializes in global equity investments, predominantly in growth sectors and compounders in the industries health care, technology, consumer and industrials with a focus on developed countries. The firm incorporates a fundamental, bottom-up stock picking process. Investment decisions are based on in-depth fundamental research into a company’s financial and business strengths/weaknesses, its growth prospect and unique industry positioning as well as the quality of management and capital returns.	Chief Executive Officer	19/09/2017

All active positions of Silvano Cominelli

Former positions of Silvano Cominelli

Companies	Position	End
Broncus Technologies, Inc. Broncus Technologies, Inc. Medical SpecialtiesHealth Technology Develops solutions for diagnosing and treating lung diseases	Director/Board Member	31/01/2013
Serono SA Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs	Corporate Officer/Principal	30/11/2000
HBM Partners AG (Investment Management) HBM Partners AG (Investment Management) Investment ManagersFinance HBM-IM invests in biopharma and other healthcare-related companies across Europe, North America, India and other Emerging Markets. Their main fund, HBM Healthcare Investments, invests in private and public companies and IPOs.	Analyst-Equity	-
Pelikan Technologies, Inc. Pelikan Technologies, Inc. Medical SpecialtiesHealth Technology Develops hand held diagnostic and monitoring devices	Director/Board Member	-

See the detail of Silvano Cominelli's experience

Training of Silvano Cominelli

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Silvano Cominelli's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Broncus Technologies, Inc. Broncus Technologies, Inc. Medical SpecialtiesHealth Technology Develops solutions for diagnosing and treating lung diseases	Health Technology
Pelikan Technologies, Inc. Pelikan Technologies, Inc. Medical SpecialtiesHealth Technology Develops hand held diagnostic and monitoring devices	Health Technology
Serono SA Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs	Health Technology
University of Zurich University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
HBM Partners AG (Investment Management) HBM Partners AG (Investment Management) Investment ManagersFinance HBM-IM invests in biopharma and other healthcare-related companies across Europe, North America, India and other Emerging Markets. Their main fund, HBM Healthcare Investments, invests in private and public companies and IPOs.	Finance
GianCom AG GianCom AG Investment ManagersFinance GianCom specializes in global equity investments, predominantly in growth sectors and compounders in the industries health care, technology, consumer and industrials with a focus on developed countries. The firm incorporates a fundamental, bottom-up stock picking process. Investment decisions are based on in-depth fundamental research into a company’s financial and business strengths/weaknesses, its growth prospect and unique industry positioning as well as the quality of management and capital returns.	Finance